Measuring severity, understanding complexity, and recognizing crisis drivers in high-support autism
“High support Autism: What We Know, What We Assume, and What We Must Demonstrate”
Abstract: Severe autism represents a heterogeneous but underserved segment of the spectrum (30%+), marked by high support needs, minimal verbal abilities, complex comorbidities, and under-representation in research. This keynote outlines the current conceptual instability around definitions and severity metrics, highlights structural biases in cohorts, and maps the central scientific gaps—biomarkers, mechanisms, longitudinal trajectories, and translational endpoints. The lecture sets the stage for a conference focused on rebuilding methodological foundations and establishing research priorities for high-support autism.
14:00–14:20 — OPENING SESSION
- Welcome & scientific rationale
- Why a meeting focused on severe autism
- Overview of the state-of-the-art paper
- Film screening
14:20–15:00 — OPENING KEYNOTE
“Severe Autism: What We Know, What We Assume, and What We Must Demonstrate”
15:00–15:30 — SYMPOSIUM 1
Rethinking Severe Autism: From ‘high support’ to Profound Autism throughout Definitions, Taxonomy & Measurement”
Abstract: This session examines why the field still lacks a stable and operational definition of “high support/severe/profound” autism. Speakers will address the coexistence of administrative (e.g., Lancet Commission) versus clinical definitions, the scarcity of validated severity cut-offs, and the exclusion of individuals with intellectual disability or minimal verbal ability from most studies and trials. Strategies for building inclusive cohorts, calibrating severity measures, and reporting recruitment flows transparently are proposed. This session provides the conceptual foundation for the entire congress, clarifying why definitions and measurement choices directly shape biological stratification, trial design, and clinical translation.
Talks:
- What Do We Mean by “Severe Autism”? Nosology & Operational Thresholds
- Underrepresented Profiles: Why Minimally/Non-Verbal & ID Individuals Rarely Enter Research Cohorts
15:45–16:00 — Transition
15:35–16:55 — SYMPOSIUM 2
“Clinical Complexity: Pain, Sleep, Sensory Overload & Comorbidities”
Abstract: High support autism frequently overlaps with hidden pain, autonomic dysregulation, aberrant sleep micro-architecture, epilepsy, gastrointestinal symptoms, and medical emergencies that shape functional severity. This symposium integrates findings from neurology, sleep medicine, autonomic neuroscience and internal medicine to illustrate how these factors alter behavior, learning, and adaptive functioning. Approaches for measurement, early detection, and research design are discussed.
Talks:
- Psychiatric Symptoms or Neuroimmune Dysregulation? A Clinical Framework for Interpreting Behavioral Change in Severe Autism
- Sleep as a Neurodevelopmental Regulator in Autism: arousal Instability, and Functional Outcomes
- Epilepsy: Unrecognized Drivers of Functional Severity
- ENT Disorders and Upper Airway Infections in Autism: From Hidden Inflammation to Neuroimmune Triggers
17:00–17:25 — Coffee Break
17:30–18:10 — SYMPOSIUM 3
“Severe Behavioral Phenotypes: Neurobiology of Self-Injury, Autonomic Crises & Aggression”
Abstract: Severe self-injurious behavior (SIB), aggression, and autonomic crisis episodes represent some of the most medically urgent and least understood phenotypes in high-support autism. This symposium examines converging neurobiological pathways—nociceptive dysfunction, endogenous opioid signaling, autonomic instability, neuroinflammatory triggers, and sensory-motor integration abnormalities—that drive extreme behavioral crises. Presentations will explore biomarkers of arousal dysregulation, the role of interoceptive pain abnormalities, early-warning physiological signatures, and the interface between medical distress and behavioral escalation. The session proposes mechanistically anchored frameworks for assessment and outlines research strategies capable of distinguishing behavioral, autonomic, and medical causes of crisis behavior.
Talks:
- Self-Injurious Behavior and Pain in Severe Autism: Current Hypotheses on Pain Perception and Defensive Responses
- Behavioral Crises in Severe Autism: Hypothesized Links to CNS Hyperresponsivity and Sensory Dysregulation
18:10–18:15 — Transition
18:15–19:35 — ASSOCIATION ANCHORING SESSION
“Why Biomedical Research Matters: Perspectives from Autism Organizations”
Abstract: Autism organizations outline the lived impact of diagnostic delays, unmet medical needs, sensory and behavioral crises, and fragmented services. Their perspective frames why mechanistic, biologically grounded research is essential to improve both care and long-term outcomes. The session anchors the congress in real-world priorities and underscores the urgency of translational science for high-support autism.
Talks:
- Clinical Complexity Through Lived Experience: Caregiver Perspective
19:35–19:40 — Transition
18:40–19:20 — POSTER AREA OPENING & NETWORKING
Comorbidities & Medical Complexity
Introduction
Autism Spectrum Disorder (ASD), particularly in individuals with high support needs, is frequently accompanied by a broad range of medical, neurological, and psychiatric comorbidities that substantially influence functional severity, developmental trajectories, and quality of life. In these populations, disability is rarely explained by core autistic features alone. Instead, medical complexity—defined as the coexistence of multiple chronic conditions requiring coordinated care—plays a central role in shaping behavior, learning capacity, and crisis vulnerability.
For minimally verbal individuals and tose with intellectual disability, medical symptoms often remain under-recognized, presenting indirectly through behavioral changes rather than verbal complaints. As a result, comorbidities are frequently misattributed to “behavioral severity,” delaying diagnosis and appropriate treatment.
Current Evidence
Neurological Comorbidities
Epilepsy is one of the most prevalent and clinically significant comorbidities in autism, with risk markedly increased in individuals with intellectual disability and severe phenotypes. Contemporary reviews confirm that epilepsy is associated with worse cognitive outcomes, higher rates of behavioral dysregulation, and increased mortality, underscoring its role as a modifier of severity rather than a secondary condition. Genetic studies further demonstrate that rare, high-impact variants associated with epilepsy and neurodevelopmental syndromes often co-segregate with high-support autism phenotypes, reinforcing the link between genomic vulnerability and medical complexity.
Gastrointestinal Disorders
Gastrointestinal (GI) symptoms—including constipation, abdominal pain, reflux, and motility disorders—are consistently reported at higher rates in autistic individuals compared with the general population. Recent systematic reviews highlight that GI symptoms are particularly common in individuals with more severe autism presentations and are associated with irritability, sleep disturbance, and challenging behaviors.
In non-speaking individuals, GI discomfort is frequently expressed through behavioral escalation or self-injury, leading to underdiagnosis and undertreatment. This reinforces the need to consider GI pathology as a core component of clinical complexity, not a peripheral issue.
Sleep Disorders
Sleep disturbances affect up to 70–80% of autistic individuals and are especially prevalent in those with high support needs. Disorders of sleep initiation, maintenance, and micro-architecture have been linked to impaired daytime functioning, learning difficulties, emotional dysregulation, and increased caregiver burden.
Importantly, sleep disruption often interacts with other comorbidities—such as epilepsy, GI disorders, and anxiety—creating self-reinforcing cycles of instability that amplify functional severity.
Immune Dysregulation and Chronic Pain
Growing evidence supports the presence of immune system alterations in subsets of autistic individuals, including changes in cytokine profiles and markers of systemic inflammation. While causality remains debated, immune dysregulation has been associated with periods of behavioral worsening and increased vulnerability to stressors.
Chronic pain—stemming from GI pathology, musculoskeletal issues, headaches, or sensory hypersensitivity—is increasingly recognized as an underappreciated driver of distress in autism, particularly in individuals unable to communicate pain verbally. Failure to identify pain contributes significantly to misinterpretation of behaviors as purely psychiatric or behavioral in origin.
Medical Emergencies and Health System Burden
Individuals with high-support autism experience higher rates of emergency department visits, hospitalizations, and adverse health outcomes compared with both neurotypical peers and autistic individuals with lower support needs. Barriers to care, communication difficulties, and fragmented service delivery exacerbate these risks, highlighting autism with medical complexity as a public health and systems-level challenge.
Research Gaps
Despite increasing awareness, major gaps remain:
- Limited prospective, longitudinal studies integrating medical comorbidities into autism outcome models.
- Lack of standardized screening protocols for pain, GI symptoms, and sleep disorders in non-verbal individuals.
- Insufficient integration of medical complexity into trial design and stratification frameworks.
- Persistent underrepresentation of medically complex individuals in autism research cohorts.
Clinical and Research Implications
Clinical Care
Recognizing medical complexity requires routine, structured screening for neurological, gastrointestinal, sleep, and pain-related conditions. Multidisciplinary care models are essential to reduce diagnostic delay and prevent avoidable crises.
Research
Future studies should treat comorbidities as core variables, not confounders, and incorporate medical phenotyping into stratification strategies. This is particularly relevant for trials targeting high-support autism populations.
Systems and Policy
Health systems must move toward integrated care pathways that address both neurodevelopmental and medical needs, reducing emergency utilization and improving long-term outcomes.
TITOL POPUP
Contingut del popup